中国实用外科杂志 ›› 2022, Vol. 42 ›› Issue (07): 833-835.DOI: 10.19538/j.cjps.issn1005-2208.2022.07.28

• 文献综述 • 上一篇    下一篇

腹腔镜手术治疗肝内胆管细胞癌研究现状

盛宇斌1,梁    霄2   

  1. 1绍兴文理学院医学院,浙江绍兴 312000;2浙江大学医学院附属邵逸夫医院普外科,浙江杭州 310000
  • 出版日期:2022-07-01 发布日期:2022-07-05

  • Online:2022-07-01 Published:2022-07-05

摘要: 肝内胆管细胞癌(ICC)是仅次于肝细胞癌的第二大原发性肝癌,发病率逐年上升,手术是唯一可能治愈ICC的方法。但由于ICC的生物学特性,腹腔镜肝切除术治疗ICC在操作规范和疗效上仍存在争议。对于ICC病人,腹腔镜肝切除术中实施淋巴结清扫安全可行,与开放手术相比,腹腔镜肝切除术具有术中出血量少、术后并发症发生率低、术后住院时间短等优势,并未增加病人围术期病死率,但在远期疗效上暂未体现优势。

关键词: 肝内胆管细胞癌, 腹腔镜肝切除术, 微创手术, 开放肝切除术, 争议

Abstract: Current situation and future prospect of laparoscopic treatment of intrahepatic cholangiocarcinoma        SHENG Yu-bin*,LIANG Xiao. *Shaoxing University School of Medicine,Shaoxing 312000,China   
Corresponding author:LIANG Xiao,E-mail:srrshlx@ zju. edu. cn
Abstract  Intrahepatic cholangiocarcinoma(ICC) is the second largest primary liver cancer only compared with hepatocellular carcinoma. The incidence rate is increasing year by year. Surgery is the only possible way to cure ICC. However, in view of the biological characteristics of ICC,laparoscopic hepatectomy(LLR) for the treatment of ICC is still controversial. It is feasible to perform lymph node dissection under the laparoscopic treatment of ICC. LLR treatment of ICC,compared with traditional open surgery(OLR),has clear advantages such as less intraoperative bleeding,fewer postoperative minor complications,shorter hospital stay,and does not increase the perioperative mortality of patients. LLR treatment of ICC has no significant advantage in the long-term efficacy.  

Key words: intrahepatic cholangiocarcinoma, laparoscopic hepatectomy, minimal invasive surgery, open hepatectomy, dispute ,